Archives

Craniospinal irradiation (CSI) is a crucial component of treatment for medulloblastoma (MB), a brain tumor clinically stratified into prognostically distinct molecular subgroups. Preclinical [...]

Nearly 50 trainee oncology doctors attended a skin cancer radiotherapy study day at Norfolk & Norwich Hospital (UK) on Saturday, supported by sponsorship from Xstrahl. The annual event, which [...]

With the 61st annual American Association of Physicists in Medicine ending, the cutting-edge preclinical research created with Xstrahl systems has once again been a main feature of the event. [...]

Tumor hypoxia reduces the effectiveness of radiation therapy by limiting the biologically effective dose. An acute increase in tumor oxygenation before radiation treatment should therefore [...]

Inhibition of ataxia-telangiectasia mutated (ATM) during radiotherapy of glioblastoma multiforme (GBM) may improve tumor control by short-circuiting the response to radiation-induced DNA damage. [...]

Chemotherapy has been successfully used to reduce radiation dose and volume for most paediatric patients. However, because of the failure of chemotherapeutic agents to cross the blood-brain [...]